e12513#Background:The Breast Cancer Index (BCI) is a gene expression-based biomarker that reports two results: BCI Predictive [BCI (H/I)], which predicts benefit from extended endocrine therapy (EET), and BCI Prognostic, which combines the Molecular Grade Index (MGI) with BCI (H/I) to ...
Focuses on the research study on breast cancer in the U.S. Percentage of women who survived from breast tumor; Cost of the National Cancer Institute to spend on breast cancer research in Bethesda, Maryland; Number of alternative therapies proven to help cure ...
Circulating tumour DNA (ctDNA) allows tracking of the evolution of human cancers at high resolution, overcoming many limitations of tissue biopsies. However, exploiting ctDNA to determine how a patient’s cancer is evolving in order to aid clinical decis
Lung cancer is the leading cause of cancer-associated mortality worldwide1. Here we analysed 1,644 tumour regions sampled at surgery or during follow-up from the first 421 patients with non-small cell lung cancer prospectively enrolled into the TRACERx study. This project aims to decipher lung ...
This article provides statistical and epidemiological data on breast cancer incidence mortality and end-results including material on various systems of clinical staging and trends with time in broad categories of types of treatment. Among women in the United States the breast is the leading site of...
Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China; Shanghai Medical College, Fudan University, Shanghai, China. BACKGROUND: The objectives of this study were to evaluate the cumulative incidence of breast cancer-specific death (BCSD) and other cause-specific death in elderl...
select article P159 - Neoadjuvant chemotherapy for male with locally advanced breast cancer Conference abstractNo access P159 - Neoadjuvant chemotherapy for male with locally advanced breast cancer R. Murashko, A. Keshabyan, A. Zandaryan, A. Stepanov ...
Comment in Breast Cancer Res Treat. 1993;25(3):283. In 1982 we constructed a prognostic index for patients with primary, operable breast cancer. This index was based on a retrospective analysis of 9 factors in 387 patients. Only 3 of the factors (tumour size, stage of disease, and ...
Whether cancer risk associated with a higher body mass index (BMI), a surrogate measure of adiposity, differs among adults with and without cardiovascular diseases (CVD) and/or type 2 diabetes (T2D) is unclear. The primary aim of this study was to evaluate separate and joint associations of ...
Gene signatures include the Oncotype Dx recurrence score (Genomic Health), PAM50-based Prosigna risk of recurrence score (NanoString), Breast Cancer Index (bioTheranostics), and EPclin (EndoPredict clinical score [Myriad Genetics]). Cutoffs for risk of recurrence score were trained separately in ...